Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JDMF | ISIN: US75062E1064 | Ticker-Symbol:
NASDAQ
14.11.24
22:00 Uhr
1,840 US-Dollar
0,000
0,00 %
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
RAFAEL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
RAFAEL HOLDINGS INC 5-Tage-Chart

Aktuelle News zur RAFAEL HOLDINGS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.11.Rafael Holdings GAAP EPS of -$0.19, revenue of $0.17M2
07.11.Rafael Holdings, Inc.: Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results31NEWARK, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the fourth quarter and the full fiscal year ended July 31, 2024. "During...
► Artikel lesen
07.11.Rafael Holdings, Inc. - 8-K, Current Report-
30.10.Rafael Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405-
09.10.Rafael Holdings, Inc. - S-4, Registration of securities, business combinations6
RAFAEL HOLDINGS Aktie jetzt für 0€ handeln
08.10.Cyclo Therapeutics secures $3 million in funding from Rafael Holdings3
08.10.Cyclo Therapeutics sichert sich 3 Millionen US-Dollar Finanzierung von Rafael Holdings2
23.08.Rafael Holdings and Cyclo Therapeutics enter merger deal4
22.08.Rafael Holdings, Inc. - 8-K, Current Report1
22.08.While FDA mulls Zevra's rare disease med, Rafael Holdings merges with Cyclo Therapeutics to push their rival candidate4
22.08.Cyclo Therapeutics falls after merger agreement with Rafael Holdings4
22.08.Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement203Cyclo Therapeutics' TransportNPC Phase 3 clinical trial for Trappsol® Cyclo for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the...
► Artikel lesen
08.08.Rafael Holdings, Inc. - 8-K, Current Report-
14.06.Rafael Holdings, Inc. - 10-Q, Quarterly Report3
14.06.Rafael Holdings, Inc. - 8-K, Current Report1
14.06.Rafael Holdings GAAP EPS of -$1.36, revenue of $0.34M2
14.06.Rafael Holdings, Inc.: Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results534NEWARK, N.J., June 14, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the third quarter and the first nine months of fiscal 2024 ended April 30...
► Artikel lesen
13.03.Rafael Holdings, Inc.: Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results481Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a majority...
► Artikel lesen
14.12.23Rafael Holdings, Inc.: Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results220NEWARK, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter of fiscal 2024 - the three months ended October 31, 2023....
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1